_p.png){kind=logo}
PRESS RELEASES
April 1, 2022
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
March 21, 2022
March 21, 2022
March 21, 2022
March 21, 2022
March 21, 2022
Ventripoint Announces DTC Eligibility Approval in the U.S.
Ventripoint Announces DTC Eligibility Approval in the U.S.
March 21, 2022
Ventripoint Announces DTC Eligibility Approval in the U.S.
March 1, 2022
Ventripoint and at the Mazankowski Heart Institute to Collaborate to Conduct a World-First Study of the Changes in Cardiac Function during Pregnancy
Ventripoint Appoints Dr. Gregory Skinner to Board of Clinical Advisors
February 2, 2022
February 3, 2022
Ventripoint Announces Sponsorship for 24th Annual Canadian Society of Echocardiography Echo Weekend
Ventripoint Hires Iconic Investor Relations LLC to Provide Investor Relations Services
January 27, 2022
Ventripoint Successfully Completes European Commission QMS Certification Surveillance Audit
January 24, 2022
January 21, 2022
Ventripoint Issues Option Grants and Reports Exercise of Options and Warrants
January 7, 2022
Ventripoint Announces Up-Listing to OTCQB Venture Market
December 21, 2021
Ventripoint Expands United Kingdom Marketing with New Distribution Partner CardioLogic
November 22, 2021
Ventripoint Provides Corporate Update on Market Adoption of VMS+ Whole-heart Analysis System
November 9, 2021
Ventripoint Passes Audit of Manufacturing Facility for Canadian and US Markets
October 21, 2021
Ventripoint Installs VMS+ 3.0 Unit at East Midlands Congenital Heart Centre
October 20, 2021
Ventripoint Diagnostics Ltd. Announces Closing of Upsized Bought Deal Offering of Units
October 13, 2021
Ventripoint Diagnostics Ltd. Announces Filing of Second Amended And Restated MD&A
October 1, 2021
Ventripoint Diagnostics Ltd. Announces Filing of Amended And Restated Interim Financial Statements And MD&A
September 28, 2021
Ventripoint Diagnostics Ltd. Announces Upside To Previously Announces Bought Deal Offering Of Units To $7 Million
September 27, 2021
Ventripoint Diagnostics Ltd. Announces $5 Million Bought Deal Offering of Units
Ventripoint Issues Option Grants to Consultants and Reports Options Exercise
September 14, 2021
Ventripoint Provides Update on Growth Initiatives and Sales
Ventripoint Issues Option Grants to Consultants and Reports Options Exercise
September 7, 2021
May 21, 2021
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
Ventripoint Also Provides a Financial Update
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
July 2, 2021
May 21, 2021
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
May 21, 2021
May 6, 2021
Ventripoint update on its Financial Status and on Warrant and Option Exercises
May 4, 2021
Ventripoint Receives Government Funding To Advance Development of Next Generation of VMS+
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
July 5, 2021
April 27, 2021
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
April 26, 2021
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
March 9, 2021
Ventripoint Passes Regulatory Inspection of Manufacturing Facility and Audit of Quality Assurance System
March 3, 2021
Ventripoint Diagnostics Receives Additional Wage Subsidy Assistance and
Updates Warrant Exercises
April 19, 2021
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
April 15, 2021
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
April 13, 2021
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious
Use of the VMS Heart Analysis System
March 16, 2021
Ventripoint JV Begins Process to have Heart Analysis System Certified for use in
COVID Patients in China
March 2, 2021
Ventripoint JV Begins Training Chinese Cardiologists in Heart Analysis System and Achieves Milestone of First Commercial Sales
February 25, 2021
Correction - Ventripoint Diagnostics Issues Shares in Final Payment of
Debenture Interest
February 23, 2021
Ventripoint Heart Analysis System to be used at the Stollery Children’s Hospital to Study Atrial Dysfunction in Children
February 16, 2021
Ventripoint Advances Sales, Marketing, and Distribution Partnership in the
Largest Market in World for Heart Disease: China
February 10, 2021
Ventripoint Diagnostics Issues Shares in Final Payment of Debenture
Interest
November 26, 2020
February 5, 2021
Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services
February 5, 2021
Ventripoint Announces Complete Conversion of Secured Convertible Debentures,Exercise of Warrants and Accelerated Expiry Date of Warrants
February 3, 2021
Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise
December 14, 2020
Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and Recovery Fund and Reminds Shareholders about Annual General Meeting Today
December 10, 2020
November 26, 2020
Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise
January 4, 2021
Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System
December 15, 2020
Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting
September 30, 2020
Ventripoint Announces Appointment to the Board of Directors and Option Grants
September 25, 2020
Ventripoint Engages Torrey Hill Capital to Provide Investor Relations Services
September 15, 2020
Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading
October 8, 2020
Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center
September 28, 2020
Ventripoint Remotely Installs Whole Heart Analysis in Major European Hospital
Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020
September 23, 2020
September 14, 2020
Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement
September 15, 2020
Ventripoint Diagnostics Announces U.S. FDA Clearance for VMS+ 3.0 Whole Heart Analysis System
October 17, 2019
St. Michael's Hospital to Receive VMS+ 3.0 Whole Heart Analysis System
October 16, 2019
DOWNLOAD PDF
November 5, 2020
Canada's Largest Cardiac Centre Receives VMS+ 3.0 Ventripoint Whole Heart Analysis System
November 3, 2020
Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment
November 3, 2020
EVENTS
2021 - 31st International Symposium on ACHD
Virtual On-Line Meeting
October 13-15, 2021
2021 - Ventripoint Annual General Meeting
Virtual On-Line Meeting
August 9, 2021
2021 - 54th Annual Meeting for European Paediatric and Congenital Cardiology
Digital
April 25-27, 2021
2021 - Annual Canadian Society of Echo Virtual Echo Weekend
Virtual On-Line Meeting
April 17-18, 2021
2020 - VENTRIPOINT ANNUAL GENERAL MEETING
Virtual On-Line Meeting
December 14, 2020
2019 - AMERICAN SOCIETY OF ECHO
Portland, OR
June 22-25, 2019
2019 - CANADIAN SOCIETY OF ECHO
Toronto, Ontario
April 11-13, 2019
2019 - AMERICAN COLLEGE OF CARDIOLOGY ANNUAL CONFERENCE
New Orleans, LA
March 16-18, 2019
2018 - EUROECHO IMAGING 2018 - EUROPEAN SOCIETY OF CARDIOLOGY
Milan, Italy
December 5-8, 2018